This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Peter Slavny, PhD
Chief Technology Officer at Iontas Ltd.


Peter received a PhD in biochemistry from the John Innes Centre in Norwich, UK. He subsequently joined the McCafferty laboratory at the University of Cambridge, UK, as a post-doctoral researcher working on therapeutic antibody discovery by phage display. He was a co-founder of IONTAS ltd in 2012, where he worked as a Project Leader running successful antibody discovery campaigns to diverse, often challenging, target classes. He is currently Chief Technology Officer at IONTAS overseeing antibody discovery and engineering.

Agenda Sessions

  • LIVE Moderated Panel Discussion and Q&A Including Audience Interaction with Speakers from On-Demand SESSION #3: ANTIBODY DISCOVERY AND DEVELOPABILITY - To prepare for this discussion/Q&A, attendees should view the presentations from Session #3 in the Watch On-Demand Sessions Tab prior to this session

  • Mammalian Cell Display to Select Developable Antibodies

    On Demand